Singapore biotech developing cancer therapies using the HER pathway.
Industry: Health Care
First Day Return: -20.2%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 03/26/2018 |
Offer Price | $7.03 |
Price Range $7.03 - $7.03 | |
Offer Shares (mm) | 6.0 |
Deal Size ($mm) | $42 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 05/04/2018 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $42 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Singapore, Singapore |
Founded | 2010 |
Employees at IPO | 47 |
Website www.aslanpharma.com |